Patents Assigned to LUNDOCH DIAGNOSTICS AB
  • METHOD OF USING FOLLISTATIN IN TYPE 2 DIABETES RISK PREDICTION
    Publication number: 20220252615
    Abstract: A method of using follistatin as a biomarker for early diagnosis and/or prediction of type 2 diabetes, liver follistatin secretion regulated by GCKR, which use is herein reported. Further, a method of composing a biomarker signature for the early prediction of type 2 diabetes in a human is herein disclosed.
    Type: Application
    Filed: March 30, 2020
    Publication date: August 11, 2022
    Applicant: LUNDOCH DIAGNOSTICS AB
    Inventor: Yang DE MARINIS